CLINICAL_TRIALS
trial_result
· 2019-12-06
Clinical Trial Update: HexafluOride, a Contrast Agent for Placenta Echo-angiography [Phase 3]
Summary
A Phase 3 clinical trial evaluating HexafluOride as a contrast agent for placenta echo-angiography has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Hospitalier Régional Metz-Thionville | Conditions: Pregnancy | Phase 3 | Status: COMPLETED